Table 2.

CRCCP Is Not Related to FOBT Rates But Significantly Increased Lifetime Endoscopy Rates among the Uninsured BRFSS 2001–2015, 50–64-year-olds

	(1)	(2)	(3)
	50–64-year-olds	50–64-year-olds	50–64-year-olds
	Ever had a blood stool test (FOBT)	Had a blood stool test in past year	Ever had a sigmoidoscopy or colonoscopy
Full Sample
Pre-reform mean, 2001–2008	.381	.159	.482
CRCCP	.004	.003	.005
	(.015)	(.012)	(.005)
Adjusted R squared	.06	.03	.10
N	926,915	920,059	927,454
Adults with a health plan
Pre-reform mean, 2001–2008	.402	.169	.510
CRCCP	.008	.006	.001
	(.015)	(.012)	(.005)
Adjusted R squared	.06	.03	.09
N	818,449	812,153	819,292
Adults without a health plan
Pre-reform mean, 2001–2008	.228	.088	.270
CRCCP	−.013	−.004	.029***
	(.013)	(.010)	(.009)
Adjusted R squared	.05	.02	.06
N	106,517	105,995	106,227

Notes: Each panel of each column shows the results from a separate regression model. The reported estimate is the coefficient on an indicator for living in a state with an active CRCCP program. The CRCCP exposure variable for the models in column 2 is adjusted to equal the share of the year prior to the interview that the individual’s state had an active CRCCP program. Additional controls in all models include: sex; five-year age group dummies; insurance mandates for colon cancer screenings; ACA expansion, Medicaid private option expansion, race/ethnicity; education; marital status; the unemployment rate; the level of HMO penetration (as a share of the population); share black; share Hispanic; and state, year, and month of interview fixed effects.

^*significant at 10%;

^**significant at 5%;

^***significant at 1%. Standard errors throughout are clustered at the state level and show in parentheses. Estimates are weighted.